Clearside Biomedical, Inc. 4 SEC Filings

Filed On	Filing
24 Feb 2025	Form 4: Thorp Clay, Director Bought 15,000 shares ($13.8K)
10 Jan 2025	Form 4: Deignan Charles A., Chief Financial Officer Granted 200,000 Employee Stock Option (right to buy)
10 Jan 2025	Form 4: Chong Ngai Hang Victor, Chief Medical Officer Granted 250,000 Employee Stock Option (right to buy)
10 Jan 2025	Form 4: Lasezkay George M, Director Granted 500,000 Employee Stock Option (right to buy)
04 Nov 2024	Form 4: Chong Ngai Hang Victor, Chief Medical Officer Bought 36,500 shares ($36.5K)
24 Jun 2024	Form 4: Chong Ngai Hang Victor, Chief Medical Officer Bought 23,500 shares ($24.9K)
21 Jun 2024	Form 4: Gibney Anthony S, Director Granted 45,000 Stock Option (right to buy)
21 Jun 2024	Form 4: Yerxa Benjamin R, Director Granted 45,000 Stock Option (right to buy)
21 Jun 2024	Form 4: Hutson Nancy J, Director Granted 45,000 Stock Option (right to buy)
21 Jun 2024	Form 4: Croarkin Richard, Director Granted 45,000 Stock Option (right to buy)
21 Jun 2024	Form 4: Edwards Jeffrey L, Director Granted 45,000 Stock Option (right to buy)
21 Jun 2024	Form 4: Humphries William D., Director Granted 45,000 Stock Option (right to buy)
21 Jun 2024	Form 4: Thorp Clay, Director Granted 45,000 Stock Option (right to buy)
21 Jun 2024	Form 4: Shaffer Christy L, Director Granted 45,000 Stock Option (right to buy)
15 May 2024	Form 4: Yerxa Benjamin R, Director Bought 7,813 shares ($10.2K)
19 Apr 2024	Form 4: Gibney Anthony S, Director Bought 6,710 shares ($8.39K) · Bought 93,290 shares ($121K)
16 Apr 2024	Form 4: Gibney Anthony S, Director Granted 45,000 Stock Option (right to buy)
20 Mar 2024	Form 4: Chong Ngai Hang Victor, CHIEF MEDICAL OFFICER Bought 30,000 shares ($48K)
18 Mar 2024	Form 4: Chong Ngai Hang Victor, CHIEF MEDICAL OFFICER Granted 450,000 Employee Stock Option (right to buy)
09 Feb 2024	Form 4: Whitmore Bradford T, 10% owner Bought 444,444 shares ($600K) · Acquired 444,444 Warrant (Open Market Purchase)

Comments